Cost-effectiveness of imipenem/cilastatin/relebactam for hospital-acquired and ventilator-associated bacterial pneumonia

• मुख्य लेखकों: Jaesh Naik (लेखक), Ryan Dillon (लेखक), Matthew Massello (लेखक), Lewis Ralph (लेखक), Zhuo Yang (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Becaris Publishing Limited, 2023-01-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Aim: This study evaluates the cost-effectiveness of imipenem/cilastatin/relebactam (IMI/REL) for treating hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia (HABP/VABP) in an 'early adjustment prescribing scenario'. Methods: An economic model was constructe...